Trade bodies representing the European prescription and over-the-counter pharma sectors have issued a call to action to regulators, asking them to accelerate the adoption of electronic product ...
Rybrevant Faspro is a subcutaneous co-formulation of amivantamab, a bispecific EGFR-directed and MET receptor-directed antibody, and hyaluronidase.
The FDA has asked manufacturers of GLP-1 agonist medicines used for weight loss to remove warnings that they may cause suicidal thoughts. The request – applying to Novo Nordisk's Wegovy (semaglutide) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results